FDA Orders Surgical Mesh Makers to Study Risks
The New York Times reports that the Food and Drug Administration has issued an order requiring manufacturers of implantable surgical mesh used to treat urinary incontinence in women to study risks associated with the product stemming from years of reports of serious injuries, including life threatening infections, linked to the medical devices.
Posted on January 5, 2012